BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05665595-completion@plaintrial.com
DTSTAMP:20261029T013853Z
DTSTART;VALUE=DATE:20250926
SUMMARY:A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pe
 mbrolizumab for Resected High-Risk Melanoma in Participants With High-Risk
  Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) — estimated completion 
 date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT05665595
URL:https://plaintrial.com/trial/NCT05665595
END:VEVENT
END:VCALENDAR